HomeEisai, Biogen get U.S. FDA approval for Alzheimer’s drug, apply for full approvalFILE PHOTO: A sign marks a Biogen facility in Cambridge

FILE PHOTO: A sign marks a Biogen facility in Cambridge

FILE PHOTO: A sign marks a Biogen facility in Cambridge, Massachusetts, U.S., March 9, 2020. REUTERS/Brian Snyder

Most Read

Meta to lay off 5% of ‘lowest performers’, plans to hire for impacted roles

January 14, 2025

Apple’s new fees for app developers under fresh EU scrutiny, Bloomberg reports

January 13, 2025

Factbox-LA blaze damage likely to be largest wildfire insured loss in US history

January 13, 2025

Eli Lilly to buy Scorpion Therapeutics’ cancer therapy for up to $2.5 billion

January 13, 2025